DGAP-News: MediClin AG / Key word(s): Quarter Results
MediClin AG: Sales above previous year and earnings improvement due to
a strong third quarter 2013 - upfront investments in specific capacity
reallocations and capacity expansions effecting business development
positively.
31.10.2013 / 16:39
---------------------------------------------------------------------
Sales above previous year and earnings improvement due to a strong third
quarter 2013 - upfront investments in specific capacity reallocations and
capacity expansions effecting business development positively.
Offenburg, October 31, 2013 - In the first nine months of FY 2013 MEDICLIN
Aktiengesellschaft (MediClin) has achieved Group sales of EUR 389.7 mill.
(9M 2012: EUR 383.8 mill.), which was EUR 5.9 mill. or 1.5 % above the
value of the comparison period. In the third quarter 2013 sales amounted to
EUR 132.3 mill. matching the high level of the second quarter of 2013 and
achieving an increase of EUR 2.6 mill. or 2.0 % against previous year's
value. The Group operating result of the first nine months 2013 was EUR 2.2
mill. (9M 2012: EUR 7.4 mill.). In the third quarter of 2013, a Group
operating result of EUR 5.8 mill. (Q3 2012: EUR 5.5 mill.) was achieved,
which was EUR 0.3 mill. up against previous year's quarter.
Thus, the sales decrease of the first quarter 2013 could be more than
compensated in the following months. The Group operating result has
continuously improved despite high costs, although it is still being below
the cumulated value of the previous year. (Q1 2013: EUR -5.9 mill.; Q2
2013: EUR 2.3 mill.; Q3 2013: EUR 5.8 mill.). For the total year of 2013
the Management Board forecasts a slight sales gain in 2013 and expects a
Group operating result at the same level as the previous year's result. The
specific capacity reallocations and capacity expansions of the last few
months will contribute to this in a positive way.
Sales increase in the segments and in the business area nursing care
In the nine-month comparison and in the quarterly comparison both segments
as well as the business area nursing care are reporting sales increases. In
the first nine months of 2013 sales of the post-acute segment was EUR 223.2
mill. (+1.1%), sales of the acute segment was EUR 153.8 mill. (+2.0%) and
the business area nursing care added sales of EUR 10.1 mill. (+3.4%) to
total sales. In the third quarter sales of the post-acute segment increased
to EUR 76.1 mill. (+1.2%), sales of the acute segment to EUR 51.8 mill.
(+3.2%) and sales of the business area nursing care to EUR 3.4 mill.
(+0.9%).
Comparing the first nine months of the financial years, segment results
were still below the previous year's value, Comparing the quarters, higher
sales affected the earnings development positively. The post-acute segment
reports for the first nine months of 2013 a segment result of EUR 1.2 mill.
(9M 2012: EUR 4.6 mill.) and for the third quarter a result of EUR 3.7
mill. (Q3 2012: EUR 3.3 mill.). In the first nine months of 2013 the acute
segment achieved a segment result of EUR 6.0 mill. (9M 2012: EUR 6.7 mill.)
and EUR 2.9 mill. in the third quarter of 2013 (Q3 2012: EUR 2.8 mill.).
In the first nine months of 2013 about EUR 13.4 mill. (9M 2012: EUR 19.8
mill.) were invested in fixed assets (brutto). Another EUR 12.7 mill. (9M
2012: EUR 12.4 mill.) were spent for service and maintenance. As of
September 30, 2013 cash and cash equivalents amounted to EUR 16.7 mill.
(31.12.2012: EUR 22.9 mill.); the equity ratio was 48.6 % (31.12.2012: 49.1
%).
MediClin employed on average 6,372 employees, calculated on the basis of
full-time staff, in the first nine months of 2013, 162 employees more than
on average compared with the in same period 2012.
The interim report as of September 30, 2013 will be available in German and
English from November 12, 2013 under www.mediclin.de.
About MediClin AG (Ticker: MED; WKN: 659 510)
MediClin AG is a nation-wide clinic operator and large provider of services
in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34
clinics and 7 nursing care facilities and 11 Medizinische
Versorgungszentren (medical care units) in 11 federal states MediClin has a
total capacity of approximately 8,100 beds. MediClins' facilities include
acute care clinics, i.e., general hospitals, special treatment facilities,
specialised hospitals and clinics for post-acute treatment and medical
rehabilitation. MediClin has approximately 8,500 employees.
MediClin â a company of the Asklepios Group.
End of Corporate News
---------------------------------------------------------------------
31.10.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: MediClin AG
OkenstraÃe 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-189
Fax: +49 (0)781 488-184
E-mail: alexandra.muehr@mediclin.de
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
237288 31.10.2013
DGAP-News: MediClin AG: Sales above previous year and earnings improvement due to a strong third quarter 2013 - upfront investments in specific capacity reallocations and capacity expansions effecting business development positively.
| Source: EQS Group AG